NEWS RELEASE

Contacts:
Lynn Banaszak Brusco, Pittsburgh Life Sciences Greenhouse, (voice) 412-770-1353

The Pittsburgh Life Sciences Greenhouse Attracts $4M Series A Funding to Region’s Life Sciences Community

Pittsburgh, September 27, 2006 – The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership focused on putting the region's life sciences industry on a fast track for growth, today announced that its portfolio company, RedPath Integrated Pathology, Inc., a Pittsburgh-based firm involved in the development of advanced molecular technologies for cancer diagnosis, has secured its Series A financing led by NewSpring Capital via its dedicated healthcare fund, Commerce Health Ventures, L.P. NewSpring Capital and the PLSG agreed to a strategic relationship in 2005 to identify compelling investment opportunities in Western Pennsylvania.

RedPath announced it closed on its Series A round of equity financing led by NewSpring Capital of King of Prussia, Pennsylvania, CID Capital of Columbus, Ohio, and other investors.

“It is important that the PLSG create relationships that facilitate additional private equity investments in the region,” said John W. Manzetti, Chief Operating Officer of the PLSG.

“NewSpring Capital’s commitment to RedPath is a great win for the region and represents the first of many investments the PLSG and NewSpring plan to allocate to the region.”

“Our investments have to meet stringent criteria of providing strong financial returns, while focusing on developing and commercializing novel science and healthcare technologies emerging in the region,” said Brian G. Murphy, Partner of NewSpring Capital . “Working actively with the PLSG, we are seeking to identify the best possible candidates in Western Pennsylvania, and RedPath quickly emerged as a good example of this investment strategy.”

About the PLSG
The Pittsburgh Life Sciences Greenhouse is a public/private partnership, founded by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System, the Commonwealth of Pennsylvania and its regional foundation community. Together with private industry and advanced research and healthcare capabilities of our institutional partners, PLSG invests in and supports the growth of regional life sciences companies in the areas of: bioinformatics; bionanotechnology; diagnostics; medical devices; medical robotics; therapeutics; and tools and services. http://www.plsg.com/

About NewSpring Capital 
NewSpring Capital, based in King of Prussia, PA, is a family of specific purpose private equity funds which includes: NewSpring Ventures, L.P., a venture capital fund providing equity capital to growth and expansion stage companies with a focus on information technology, business services and healthcare; Commerce Health Ventures, L.P., a venture capital fund focused on life science and healthcare companies; and NewSpring Mezzanine Capital, L.P., a regionally focused mezzanine debt fund that invests in information technology, business services, healthcare and specialty manufacturing. http://www.newspringcapital.com/

# # #